- Home
- RIGL vs ZEUS Comparison
RIGL vs ZEUS Comparison
Compare RIGL & ZEUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- ZEUS
- Stock Information
- Founded
- RIGL 1996
- ZEUS 1954
- Country
- RIGL United States
- ZEUS United States
- Employees
- RIGL N/A
- ZEUS N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- ZEUS Metal Fabrications
- Sector
- RIGL Health Care
- ZEUS Industrials
- Exchange
- RIGL Nasdaq
- ZEUS Nasdaq
- Market Cap
- RIGL 335.5M
- ZEUS 352.6M
- IPO Year
- RIGL 2000
- ZEUS 1994
- Fundamental
- Price
- RIGL $38.85
- ZEUS $33.71
- Analyst Decision
- RIGL Buy
- ZEUS Buy
- Analyst Count
- RIGL 5
- ZEUS 1
- Target Price
- RIGL $38.20
- ZEUS $38.00
- AVG Volume (30 Days)
- RIGL 995.6K
- ZEUS 55.6K
- Earning Date
- RIGL 08-05-2025
- ZEUS 10-30-2025
- Dividend Yield
- RIGL N/A
- ZEUS 1.90%
- EPS Growth
- RIGL N/A
- ZEUS N/A
- EPS
- RIGL 5.43
- ZEUS 1.23
- Revenue
- RIGL $267,921,000.00
- ZEUS $1,878,204,000.00
- Revenue This Year
- RIGL $59.93
- ZEUS $0.48
- Revenue Next Year
- RIGL N/A
- ZEUS $2.77
- P/E Ratio
- RIGL $7.15
- ZEUS $27.48
- Revenue Growth
- RIGL 105.62
- ZEUS N/A
- 52 Week Low
- RIGL $12.66
- ZEUS $26.32
- 52 Week High
- RIGL $43.72
- ZEUS $43.60
- Technical
- Relative Strength Index (RSI)
- RIGL 68.57
- ZEUS 58.07
- Support Level
- RIGL $39.00
- ZEUS $33.15
- Resistance Level
- RIGL $42.08
- ZEUS $34.07
- Average True Range (ATR)
- RIGL 2.32
- ZEUS 0.81
- MACD
- RIGL -0.37
- ZEUS 0.23
- Stochastic Oscillator
- RIGL 53.26
- ZEUS 86.91
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About ZEUS Olympic Steel Inc.
Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.